Highly sensitive histamine-sensitization test for residual activity of pertussis toxin in acellular pertussis vaccine

Biologicals

Volumn 35, Issue 4, 2007, Pages 259-264

  Ochiai, Masaki ^a   Yamamoto, Akihiko ^a   Kataoka, Michiyo ^a   Toyoizumi, Hiromi ^a   Arakawa, Yoshichika ^a   Horiuchi, Yoshinobu ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Histamine sensitization test; Pertussis vaccine; Quality control

Indexed keywords

HISTAMINE; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DETERMINATION; DRUG QUALITY; DRUG SAFETY; EVALUATION; FEMALE; HISTAMINE SENSITIZATION TEST; INFRARED THERMOMETER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN TEMPERATURE;

ANIMALS; BODY TEMPERATURE; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HISTAMINE; MICE; PERTUSSIS TOXIN; PERTUSSIS VACCINE; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; SKIN TEMPERATURE; THERMOMETERS;

ANIMALIA; MUS;

EID: 35248863979     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2007.01.004     Document Type: Article

References (14)

1. Kanai K. Japan's experience in pertussis epidemiology and vaccination in the past thirty years. Jpn J Med Sci Biol 33 3 (1980) 107-143
2. Sato Y., Kimura M., and Fukumi H. Development of a pertussis component vaccine in Japan. Lancet 1 8369 (1984) 122-126
3. Kuno-Sakai H., Kimura M., and Watanabe H. Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan. Biologicals 32 1 (2004) 29-35
4. Pittman M. Determination of the histamine sensitizing unitage of pertussis vaccine. J Biol Stand 3 2 (1975) 185-191
5. Kurokawa M. Toxicity and toxicity testing of pertussis vaccine. Jpn J Med Sci Biol 37 2 (1984) 41-81
6. Kind L.S. Antagonism of cortisone to body temperature reducing effect of histamine. Proc Soc Exp Biol Med 85 2 (1954) 371-372
7. Ishida S., Kurokawa M., Asakawa S., and Iwasa S. A sensitive assay method for the histamine-sensitizing factor using change in rectal temperature of mice after histamine challenge as a response. J Biol Stand 7 1 (1979) 21-29
8. Ministry of Health, Labour and Welfare, Japanese Government. Minimum Requirements for Biological Products; 2004.
9. World Health Organization. Guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines. WHO Technical Report Series 878 (1998) 57-76
10. Finney D.J. Statistical methods in biological assay. 3rd ed. (1978), Charles Griffin Co. Ltd., London
11. Xing D., Das R.G., Newland P., and Corbel M. Comparison of the bioactivity of reference preparations for assaying Bordetella pertussis toxin activity in vaccines by the histamine sensitisation and Chinese hamster ovary-cell tests: assessment of validity of expression of activity in terms of protein concentration. Vaccine 20 29-30 (2002) 3535-3542
12. Manclark C.R., Hansen C.T., Treadwell P.E., and Pittman M. Selective breeding to establish a standard mouse for pertussis vaccine bioassay. II. Bioresponses of mice susceptible and resistant to sensitization by pertussis vaccine HSF. J Biol Stand 3 4 (1975) 353-363
13. Munoz J.J., and Bergman R.K. Bordetella pertussis: immunological and other biological activities. Immunology vol. 4 (1977), Marcel Dekker Inc., New York and Basel
14. Iwasa S., Ishida S., Asakawa S., and Akama K. A curious histamine-sensitizing activity shown by the newly-developed Japanese acellular pertussis vaccine. Dev Biol Stand 61 (1985) 453-460